Low-risk localized prostate cancer: are we ready to tell patients that active surveillance is the preferred option?
Brewster
Simon F
SF
Department of Urology, Churchill Hospital, Oxford, UK. simon.brewster@orh.nhs.uk
D006801:Humans; D008297:Male; D017060:Patient Satisfaction; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000523:psychology / Q000628:therapy*; D018570:Risk Assessment / Q000592:standards; D012307:Risk Factors
D017430:Prostate-Specific Antigen